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Abstract
Growing evidence indicates that the defining characteristics of autism spectrum
disorder (ASD) are distributed throughout the general population; hence, under-
standing the correlates of aging in people with high autistic traits could shed light
on ASD and aging. 915 members of the Dunedin longitudinal birth cohort com-
pleted a measure of autistic traits at age 45. A composite measure of the “pace of
aging” was derived by tracking the decline in 19 biomarkers across ages 26, 32,
38, and 45 years. Facial age was also assessed. Reports of perceived health were
collected from participants themselves, informants, and interviewers. Higher self-
reported autistic traits significantly correlated with a faster pace of aging, older
facial age, and poorer self-, informant-, and interviewer-rated health. After con-
trol for sex, SES and IQ, autistic traits were significantly associated with each var-
iable: pace of aging (β = 0.09), facial age (β = 0.08), self- (β = 0.15), informant
(β = 0.12), and interviewer-rated (β = 0.17) health. Autistic traits measured at
age 45 are associated with faster aging. Participants with high autistic traits
appear to be more vulnerable to poor health outcomes, as previously reported for
those clinically diagnosed with ASD. Therefore, autistic traits may have impor-
tant health implications. Replicating these findings in samples of autistic people is
needed to identify the mechanism of their effect on aging and physical health to
improve outcomes for those with ASD diagnoses or high autistic traits.
Lay Summary: The role that autistic traits have in relation to health outcomes has
not been investigated. We looked at how physical health and aging (measured
with self-reported questions and decline in multiple biological measures) were
related to autistic traits (measured with a questionnaire, at age 45). We found that
higher autistic traits were associated with poorer reports of physical health, and a
faster pace of aging. This suggests that both those with autism and those with
higher autistic traits may be more likely to experience poorer health outcomes.
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INTRODUCTION
There is a small, but expanding, research literature about
the physical health status of autistic people (Cashin
et al., 2018). Autism Spectrum Disorder (ASD; hereafter
“autism,” “autistic people,” or “on the autism spectrum”;
Kenny et al., 2016) is a neurodevelopmental condition
characterized by atypical social and communication style
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and restricted interests and/or repetitive behaviors
(American Psychological Association, 2013). Autism is
associated with neurological conditions, and with ele-
vated rates of both psychiatric and physical health com-
orbidities. Autistic people are more likely to experience
premature mortality; approximately 12 years earlier for
people on the autism spectrum and 30 years earlier
for those with co-occurring intellectual disability
(Hirvikoski et al., 2016). Several studies have reported
elevated rates of a range of physical health conditions
across the lifespan. One study of electronic health records
with autistic children (aged 3 to 9) reported elevated rates
of autoimmune, endocrine, and genetic disorders com-
pared to age and gender-matched comparison samples
(N = 3926 and N = 39,224 respectively; Cummings
et al., 2016), and the same study found elevated rates of
endocrine and genetic disorders in autistic adolescents
(N = 4399 and N = 43,951 matched comparison partici-
pants; Cummings et al., 2016). This is consistent with
parental report, with parents reporting greater rates of
bone, joint, or muscle problems, food allergies, and hear-
ing or vision problems in autistic children compared to
nonautistic children (Gurney et al., 2006). In adulthood,
a large study from Northern California examined medi-
cal insurance records and found that autistic adults
(N = 1507) had elevated rates of a range of age-related
health conditions compared with matched controls
(N = 15,070), including: cardiovascular disease
(OR = 2.54), diabetes (OR = 2.18), Parkinson’s disease
(and spectrum; OR = 32.7), nutrition conditions (e.g.,
vitamin deficiency, OR = 2.68), and obesity (OR = 1.41)
(Croen et al., 2015). Consistent with this, a separate study
found elevated rates of physical conditions, notably sei-
zures and hypertension, in a survey of 255 autistic adults
(aged 18 to 71; Fortuna et al., 2016). Further, two studies
using Scottish census data reported elevated rates of
physical disability, sight and hearing loss in autistic
adults (Rydzewska et al., 2018; Rydzewska et al., 2019).
Despite rates of physical health conditions being ele-
vated in samples of autistic children and adults across the
lifespan, it is notable that several of the physical disorders
elevated in autism are generally more prevalent with
advancing age. There is a conspicuous lack of research
about the aging process and autism (Happé &
Charlton, 2012; Wright et al., 2019). This may be because
the earliest research cohorts of autistic children are only
now reaching older adulthood (Mukaetova-Ladinska &
Stuart-Hamilton, 2016), and many older autistic people
go undiagnosed; the so-called ‘missing generation’
(Barnhill, 2007). The few studies of older autistic adults
have reported primarily on cognition and mental health
(e.g., Lever & Geurts, 2016; Uljarevic et al., 2019). To
date there is only one study of physical health focused on
older autistic people; a retrospective cohort study of
Medicare records from 4685 autistic adults aged 65 or
older reported elevated rates of age-related conditions
including osteoporosis, osteoarthritis, heart disease,
cancer, and cerebrovascular disease (Hand et al., 2020).
These findings raise the possibility that the pace of aging
(described below) is accelerated in autism, increasing the
risk of age-related health problems.
Pace of aging reflects declining function across a range
of bodily systems including cardiovascular, metabolic,
renal, immune, dental, and pulmonary systems (Moffitt
et al., 2017). Hence, pace of aging taps individual changes
in biological processes rather than simply measuring chro-
nological age (Belsky et al., 2017); two people of the same
age may differ radically in their pace of aging.
To date, studies have explored health outcomes or
mortality using a categorical distinction between those
clinically diagnosed with autism and matched controls.
There is growing evidence, however, that the characteris-
tics associated with autism (social and communication
difficulties, repetitive behaviors), as measured by self-
report instruments such as the Autism Quotient (AQ;
Allison et al., 2012), are continuously distributed in the
general population (Constantino & Charman, 2016;
Ruzich et al., 2015). Twin studies suggest that the same
genetic influences act on diagnosed autism, extreme autis-
tic traits, and subclinical autistic traits (Colvert
et al., 2015; Lundström et al., 2012; Robinson, Koenen,
et al., 2011; Ronald et al., 2006) and molecular genetic
studies concur with these findings (Massrali et al., 2019;
Robinson et al., 2016; Stergiakouli et al., 2017). A twin-
study comparing co-twins with, and without an autism
diagnosis found that neurological conditions (epilepsy,
vertigo, headache, brain injury, and hearing impairment)
were associated with autistic traits (however, immunolog-
ical conditions were not; Pan et al., 2019). A recent study
found that adults (aged 50 years or older, mean age
62 years) who self-reported high autistic traits were more
likely than those without such traits to experience diffi-
culties with sleep, depression, and anxiety (Stewart
et al., 2020b). Thus, taking a dimensional approach to
autistic traits may provide additional information about
physical health and the pace of aging in autism.
The present study investigated the association between
autistic traits and several markers of aging (pace of aging,
facial age, self-, informant-, and interviewer-rated health)
measured at age 45, accounting for childhood and adult-
hood demographics. Specifically, we hypothesized that:
(a) autistic traits would be associated with a faster pace of
aging; (b) autistic traits would be associated with older
facial age; and (c) autistic traits would be associated with
poorer self-, informant- and interviewer-rated health.
METHODS
Sample
Participants are members of the Dunedin Study, a longi-
tudinal investigation of health and behavior in a repre-
sentative birth cohort. The 1037 participants (91% of
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eligible births, the remaining 9% declined participation,
or were unable to participate; Poulton et al., 2015) were
all individuals born between April 1972 and March 1973
in Dunedin, New Zealand, who were eligible on the basis
of residence in the province and who participated in the
first assessment at age 3 years (Poulton et al., 2015). The
cohort represents the full range of socioeconomic status
(SES) in the general population of New Zealand’s South
Island and, as adults, matches the New Zealand National
Health and Nutrition Survey on key adult health indica-
tors (e.g., body mass index, smoking, and general practi-
tioner visits) and the New Zealand Census of citizens of
the same age on educational attainment (Poulton
et al., 2015). The cohort is primarily white (93%, self-
identified), matching South Island demographic charac-
teristics. Assessments were performed at birth; at ages
3, 5, 7, 9, 11, 13, 15, 18, 21, 26, 32, and 38 years; and,
most recently (completed April 2019), at age 45 years,
when 938 of the 997 participants (94.1%) still alive partic-
ipated. Of the 938 participants who took part, 23 did not
have AQ-10 data (see Measures), and so were excluded.
Therefore, the final sample comprised 915 participants.
Study members with data available at age 45 years did
not differ significantly from other living participants in
terms of childhood SES and childhood IQ (Carlisi
et al., 2020). At each assessment, each participant was
brought to the research unit for interviews and examina-
tions. Research staff (hereafter “interviewer”) make stan-
dardized ratings, informant questionnaires are collected,
and administrative records are searched.
Measures
Autism Quotient-10 (AQ-10; Allison et al., 2012): This is
a 10-item adaptation of the longer 50-item AQ, designed
to screen for autistic traits in children and adults. Self-
report questions tap behaviors or cognitions characteris-
tic of ASD, such as attention to detail (e.g., “I usually
concentrate more on the whole picture, rather than the
small details”), attention switching (e.g., “I find it easy to
do more than one thing at once”), or communication
(e.g., “I find it easy to ‘read between the lines’ when
someone is talking to me” reverse coded). Each item is
answered on a 4-point Likert scale (strongly disagree, dis-
agree, agree, strongly agree). When scoring, responses
are dichotomised to give a 1 or 0 score (i.e., “strongly
agree” and “agree” responses would be collapsed and
scored 1 for an item that indicates an autistic trait). The
measure is a short form of the full AQ, which was
intended to capture 5 constructs (detail focus, attention
switching, communication, imagination, and social).
However, we opted to use only the total score. Greater
scores indicate more autistic traits; a score of 6 indicates
a potential need for a full autism diagnostic assessment
(Allison et al., 2012). The sensitivity and specificity of the
AQ-10 have been reported as 79.9% and 87.3%,
respectively (in a sample comprised of autistic and gen-
eral population participants; Booth et al., 2013).
Cronbach’s alpha for those completing the measure was
0.60, indicating acceptable internal reliability, albeit
somewhat lower than other published studies with gen-
eral population samples (e.g., 0.85, Allison et al., 2012;
0.67 to 0.73, depending on age, Lundin et al., 2019).
Demographic data: The SES of participants’ childhood
families was measured using the six-point Elley-Irving
Socioeconomic Index for New Zealand (Elley &
Irving, 1976). This measure was derived from Statistics
New Zealand, from their census, and includes income, edu-
cation level, and prestige for each occupation in
New Zealand. Childhood SES represented the average of
the highest SES level of either parent across the assessments
of cohort families from the study member’s birth through
age 15 years (M = 3.8, SD = 1.1, range = 1 to 6).
Childhood IQ data were obtained from assessments
conducted when participants were aged 7, 9, and 11 years.
Full scale IQ scores were assessed using the Wechsler Intel-
ligence Scale for Children- Revised (WISC-R;
Wechsler, 1974). Scores were averaged across the three
childhood assessments to yield a childhood IQ score.
Pace of aging: This was measured for each Dunedin
participant with repeated assessments of an established
panel of 19 biomarkers taken at ages 26, 32, 38, and
45 years, and employed as previously described (Belsky
et al., 2015; Elliott et al., 2021). The 19 biomarkers cover
the main aspects of aging and were as follows: body mass
index, waist-hip ratio, glycated hemoglobin, leptin, mean
arterial pressure, cardiorespiratory fitness, forced expira-
tory volume in 1 s (FEV1), FEV1 to forced vital capacity
ratio, total cholesterol, triglycerides, high-density lipo-
protein cholesterol, apolipoprotein B100/A1 ratio,
lipoprotein(a), creatinine clearance, urea nitrogen, C-
reactive protein, white blood cell count, mean periodon-
tal attachment loss (AL), and caries-affected tooth sur-
faces. Measures were taken in counterbalanced order
across participants except for blood and dental examina-
tions which were both conducted in the late afternoon at
all four phases. Women who were pregnant at the time of
a given assessment were included in that wave of data
collection, except blood biomarkers were not collected.
Change over time in each biomarker was modeled with
mixed-effects growth models, and these rates of change
were combined into a single index scaled (within sex) in
years of physiological change occurring per one chrono-
logical year using a previously described method (Belsky
et al., 2015). Briefly, the biomarkers were standardized to
a mean of 0 and SD of 1 based on the age 26 distribu-
tions. Mixed effect growth models were used to estimate
each participants’ slope over the four study occasions for
each biomarker individually. These slopes were then
summed and scaled so that 1 year of chronological age
equated roughly to 1 year of average change in physio-
logical functioning in the sample. Participants ranged in
their Pace of Aging from 0.4 years of physiological
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change (slow aging) per chronological year to 2.4 years
of physiological change per chronological year (fast
aging).
Facial aging: Facial age is a valid biomarker of aging
that predicts mortality above and beyond other relevant
measures of health, as shown in MZ co-twins discordant
for facial age (Christensen et al., 2009). The measure was
based on two measurements of perceived age using rat-
ings of each participant’s facial photograph by an inde-
pendent panel of eight raters. First, Age Range was
assessed by an independent panel of four raters, who
were presented with standardized (non-smiling) facial
photographs of participants and were kept blind to their
actual age. Raters used a Likert scale to categorize each
participant into a 5-year age range (i.e., from 20 to
24 years old up to 70+ years old) (interrater reliabil-
ity = 0.77). Scores for each participant were averaged
across all raters. Second, Relative Age was assessed by a
different panel of four raters, who were told that all
photos were of people aged 45 years old. Raters then
used a seven-item Likert scale to assign a “relative age”
to each participant (1 = “young looking,” 7 = “old
looking”) (interrater reliability = 0.79). The measure of
perceived age at 45 years was derived by standardizing
and averaging age range and relative age scores.
Perceived health: We obtained three reports about
study members’ health from three sources: self-reports,
informant impressions, and interviewer impressions.
Interviewers met with study participants for an hour of
data collection. As part of the data collection a multi-
item checklist was used by the interviewer, about the
study member. The item used to measure interviewer-
rated health was “In general, how is SMs health?”
(response options: poor, fair, good, very good, excellent).
Each study member identified three people who could act
as informants about them (i.e., someone who knows them
well). Each informant is then asked to complete a series
of questionnaires about the study member (95% had at
least one informant questionnaire completed; 60% had
all three completed). The item used to measure
informant-rated health was “How would you rate their
fitness?” (response option: poor, fair, good, very good,
excellent). Correlations between self-, informant-, and
interviewer-ratings ranged from 0.48 to 0.55.
Data analysis
The study’s preregistration materials can be accessed
online at https://sites.google.com/site/moffittcaspiprojects/
home/projectlist/happe_2019. All continuous variables
were inspected for normality using histograms and descrip-
tive statistics (skew and kurtosis). Pearson’s correlations
were used to investigate the associations between AQ-10
score and the dependent variables of adulthood aging and
health variables (pace of aging, facial age, self-reported
health, informant-rated health, and interviewer-rated
health). To control for spurious associations due to low IQ
or SES present from childhood, multiple regression was
used to test whether AQ-10 score statistically predicted the
aging and health variables over and above the effects of
these childhood variables (childhood IQ, childhood SES
and sex). We did not include SES in adulthood because
this was coded based on occupation at age 45 which may
be a consequence of elevated autistic traits; thus, adult-
hood SES is not a variable in need of statistical control to
address the present research question. All analyses were
conducted in SPSS version 25 (IBM Corp., 2017); JASP
version 0.13.1 (JASP Team, 2020) was used to calculate
effect sizes with confidence intervals.
RESULTS
As expected, males reported significantly higher AQ-10
scores than females (mean = 2.0, SD = 1.7 and
mean = 1.5, SD = 1.7, respectively; t[913] = 5.2,
p < 0.001), but the effect size was small (Cohen’s
d = 0.34). Child and adult data for the study participants
with AQ-10 data are shown in Table 1. Note, due to
incomplete data, the sample size for each measure is dif-
ferent. Sample size ranges from N = 877 for informant-
rated health, to 915 for self-rated health and AQ-10.
Are autistic traits associated with physical health
and aging?
AQ-10 total score was significantly correlated with each
dependent variable. People who reported more autistic
traits at age 45 tended to have a faster pace of aging
(r = 0.16, p < 0.001), older facial age (r = 0.14,
p < 0.001), worse self-reported health (r = 0.21,
p < 0.001), poorer informant-rated health (r = 0.13,
p < 0.001), and poorer interviewer-rated health
(r = 0.22, p < 0.001). See Table 2 for intercorrelations
between study variables (see Table S1 for correlations
between AQ-10 total, pace of aging, facial age, self-,
interviewer-, and informant-rated health, controlling for
childhood SES and childhood IQ, and Figure S2 for plots
of these relationships).
Although the main focus of this study was on autistic
traits measured dimensionally, we also report a categorical
analysis, using the indicated cut-off of six on the AQ-10
(Allison et al., 2012). A total of 38 participants (4.2%) were
categorized as having “high autistic traits”, 22 of whom
were male. Pace of aging, facial age, self-reported health,
and interviewer-rated health were all significantly different
between the high and low autistic trait groups, whereby
individuals with higher autistic traits fared worse. No signif-
icant difference was observed for informant-rated health
(see Table 3 and Figure 1). Based on the operationalization
of a previous study, we examined “slower,” “average,” and
“faster” agers (Belsky et al., 2017). More than twice as
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many people in the high autistic trait group (31.6%) were
faster agers, compared with 13.3% of the low trait group
(see Supplementary Material, Figure S1).
Are autistic traits associated with faster aging
and poorer health over and above sex, IQ,
and SES?
To test the hypothesis that autistic traits statistically pre-
dict aging and health variables, over and above the
effects of sex, childhood IQ and SES, a series of multiple
regression models were run. Model 1 included sex,
childhood SES, and childhood IQ. Model 2 was identical
to model 1 except dimensional autistic traits were
included as a predictor of health and aging variables.
Models 1 and 2 were significant for each dependent vari-
able; moreover, the change in variance explained by
adding autistic traits was significant for each dependent
variable. Variance explained for Model 2 ranged from
2.8% (for informant-rated health) to 13.5% (for
interviewer-rated health). Being female was a significant
statistical predictor of worse self-rated health, but better
interviewer-rated health. People with higher childhood
IQ or SES tended to have a slower pace of aging and
younger facial age, and higher self-, informant-, and
TABLE 1 Number of participants, mean (SD), and range for each study variable collected from Dunedin study participants
Variable N Mean SD Range
AQ-10 score at age 45 years Self-reported 915 1.7 1.7 0–10
Full scale IQ Childhooda 904 100.7 14.0 45.0–140.7
Socio economic status Childhoodb 910 3.8 1.1 1–6
Biological aging variables Pace of agingc 913 1.0 0.3 0.4–2.4
Facial aged 900 0.0 1.0 2.9–3.1
Health variables Self-reported 915 3.7 0.9 1–5
Informant-reported 877 3.8 0.8 1–5
Interviewer-rated 915 3.3 0.7 1–5
aAggregated WISC-R scores from ages 7, 9, and 11.
bAggregated from the participant’s childhood family from birth through to age 15.
cAggregated from 19 biomarkers collected at 26, 32, 38, and 45, represents number of years aged per chronological age.
dz-score.
TABLE 2 Correlations between AQ-10, childhood characteristics, aging, and health variables
1 2 3 4 5 6 7 8
1 AQ-10 1.000
2 Childhood SES 0.139** 1.000
3 Childhood IQ 0.239** 0.410** 1.000
4 Pace of aging 0.155** 0.246** 0.293** 1.000
5 Facial age 0.136** 0.244** 0.251** 0.326** 1.000
6 Self-rated health 0.205** 0.175** 0.161** 0.351** 0.236** 1.000
7 Informant-rated health 0.133** 0.121** 0.097** 0.384** 0.249** 0.478** 1.000
8 Interviewer-rated health 0.223** 0.258** 0.301** 0.584** 0.460** 0.510** 0.546** 1.000
*p < 0.05; **p < 0.01.











Pace of aging 1.13 (0.36) 0.99 (0.29) 2.29 (0.028) 0.46 0.14, 0.79
Facial age 0.45 (0.99) 0.02 (0.99) 2.87 (0.004) 0.48 0.15, 0.80
Self-rated health 3.26 (0.92) 3.67 (0.89) 2.76 (0.006) 0.48 0.13, 0.78
Interviewer-rated
health
2.87 (0.81) 3.28 (0.72) 3.43 (0.001) 0.56 0.24, 0.89
Informant rated health 3.67 (0.87) 3.78 (0.83) 0.79 (0.433) 0.13 0.20, 0.46
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interviewer-rated health. Finally, those with more autistic
traits tended to have a faster pace of aging, older facial
age, and poorer self-, informant-, and interviewer-rated
health, over and above the effects of childhood IQ and
SES. The results of the regression, including standardized
β weights, are presented in Table 4 (See Table S2 for
unstandardized B coefficients, with 95% confidence
intervals).
DISCUSSION
This study tested for the first time the hypothesis that
autistic traits are associated with aging and physical
health. Data from a population-representative cohort of
nearly 1000 participants who had completed the AQ-10
measure of self-reported autistic traits at age 45 showed a
significant correlation between autistic traits and mea-
sures of aging and physical health. In line with our
hypotheses, regression models showed that a higher AQ-
10 score was associated with faster aging and older
facial age.
Importantly, autistic traits measured continuously at
age 45 were still significantly associated with both the
pace of aging and facial age scores even when controlling
for childhood SES and IQ. Although modest, the correla-
tion coefficients between the AQ-10 and both pace of
aging and facial age are similar to those consistently
F I GURE 1 Violin plots comparing participants with high (label 1) and low (label 0) autistic traits. The y-axis is the standardized score of each
variable and indicates the probability of observing that score in each group (wider plot indicates greater probability of observing that particular z-
score). Plot (a) pace of aging at age 45; (b) facial age at 45; (c) self-rated health at 45; (d) interviewer-rated health at 45; and (e) informant-rated
health at 45
TABLE 4 Results of the multiple regression analyses for the final model
Pace of aging Facial age Self-rated health Informant-rated health Interviewer-rated health
Adjusted R2
Model 1a 0.104*** 0.085*** 0.050*** 0.015** 0.110***
Model 2b 0.110*** 0.089*** 0.071*** 0.028*** 0.135***
Predictors Standardized β
Model 2
AQ traits 0.086* 0.073* 0.153*** 0.122** 0.170***
Sex 0.001 0.036 0.081* 0.042 0.084**
Childhood SES 0.147*** 0.161*** 0.119** 0.091* 0.157***
Childhood IQ 0.216*** 0.170*** 0.088* 0.034 0.185***
aIncluded sex, childhood SES, childhood IQ.
bIncluded sex, childhood SES, childhood IQ, autistic traits.
*p < 0.05; **p < 0.01; ***p < 0.001.
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reported between childhood IQ/SES and pace of aging in
other studies (Belsky et al., 2017; Schaefer et al., 2016).
Childhood SES is strongly associated with a range of phys-
ical health outcomes, irrespective of the SES one attains in
adulthood (Poulton et al., 2002). However, our regression
analyses suggest that autistic traits (measured dimension-
ally) may add a “cost” to aging over and above the effects
of lower childhood IQ and SES. We also used the AQ-10
dichotomously, to characterize a small group of partici-
pants with high autistic traits; high and low trait groups
showed significant differences in the aging/physical health
measures in line with the correlational analyses.
Autistic traits statistically predicted poor physical
health as reported by the participant, the interviewer, and
an informant who knew the participant well. Considering
the self-report data first, in samples of clinically diag-
nosed autistic people (Ayres et al., 2018), and non-
autistic samples (Pisula et al., 2015), higher self-reported
autistic traits are consistently associated with poorer
quality of life (QOL) - a multidimensional construct that
typically includes physical well-being/health (e.g., the
WHOQoL-BREF; Whoqol Group, 1998). Specifically,
Mason et al. (2018) found that, in a sample of autistic
people, higher self-reported autistic traits were signifi-
cantly associated with poorer physical QOL, and Lawson
et al. (2020) found that autistic traits explained 20% of
the variance in physical QOL for their autistic
participants.
Considering the informant- and interviewer-rated
physical health findings, these suggest that characteristics
associated with elevated autistic traits lead to summative
judgments that physical well-being is not optimal.
Researchers and informants may be influenced by appar-
ent facial age in making their health judgments; facial
age is used by clinicians as a source of information about
health, as it reflects tissue integrity (Schaefer et al., 2016)
and is a robust predictor of mortality in older cohorts
(Christensen et al., 2009). Thus, those higher in autistic
traits may be aging faster, which is reflected in how they
look, which in turn affects how others judge their health.
Taken together, then, the “cost” of higher autistic traits
on aging and perceived health suggests that a short mea-
sure of autistic traits might possibly be a useful addition
to existing physical health checks for older adults.
Several explanations could account for our findings.
First, there may be polygenic effects underlying both
aging and autistic traits. It may be that genetic factors
underlying individual differences in the aging process,
specifically for faster aging, overlap with the genetic load-
ing for higher autistic traits. As aging largely occurs due
to cells becoming less able to repair cellular damage
(Adams & White 2004), it may be that these cellular
mechanisms are less effective in those with a higher
genetic propensity for autism. This could be tested with a
polygenic score methodology, or by examining pace of
aging in the first-degree relatives of autistic probands.
This has not, to our knowledge, been done—although
Stewart et al. (2020a) did compare health in older adults
(aged 50+) with versus without a relative diagnosed with
autism. They found higher rates of a range of mental
health conditions (e.g., major depressive disorder and
social anxiety), but not physical health conditions
(e.g., high blood pressure, stroke, heart disease) except
for endocrine conditions. Stewart et al. note that their
volunteer sample may be an unusually healthy one;
their reported prevalences for physical health conditions
are lower than general population norms. Therefore,
future work should examine putative genetic effects
underlying both aging and autistic traits.
A second explanation could be that autistic traits
impact lifestyle in a way that hastens aging. For example,
autistic adults typically report reduced social networks
(Howlin & Magiati, 2017). In older typically developing
samples a link between social isolation and unhealthy
lifestyles (such as smoking, or inactivity) has been
reported (Kobayashi & Steptoe, 2018). Further, a recent
meta-analysis found that loneliness was a risk factor for
all-cause mortality (Rico-Uribe et al., 2018). Thus, if
those with higher autistic traits are susceptible to
impoverished social networks, and similar concomitant
behaviors, it seems reasonable to conclude that the conse-
quence will be poorer health and aging outcomes.
A third possible explanation for more rapid aging in
those with elevated autistic traits might relate to common
comorbidities associated with autism/autistic traits. In
clinical samples of diagnosed autistic people these include
sleep problems in childhood (Verhoeff et al., 2018) and
adulthood (Ballester et al., 2019); and poor mental
health, particularly increased rates of anxiety and depres-
sion (Croen et al., 2015; Howlin & Magiati, 2017). Qual-
ity of sleep has been linked to physical and mental
function (Stanley, 2005) and facial aging (Oyetakin-
White et al., 2015). In the general population, comparing
older adults with versus without high autistic traits, Stew-
art et al. (2020b) found the high trait group reported
more sleep problems, even after adjusting for their higher
levels of depression and anxiety.
A fourth explanation might operate through life
events and experiences. Autistic people are subject to
higher rates of bullying, victimization, and stigma (Van
Roekel et al., 2010). Thus, higher autistic traits may be
correlated with an increased allostatic load, from multi-
ple stressor sources, that consequently accelerates aging
(Seeman et al., 2010). Testing these four hypotheses is
beyond the scope of the current paper but could be
addressed in future studies.
In our introduction, we describe the literature on
health conditions for autistic people. This study presents
an analysis of autistic traits in a large, representative
sample general population sample. It seems appropriate,
therefore, to consider to what degree our findings can be
generalized to the autistic population. First, this study is
based on the gathering evidence that autistic traits are
continuously distributed and those with an autism
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diagnosis lie at the tail of this distribution (Spiker
et al., 2002). However, some authors argue that autism
trait studies do not necessarily address key issues about
diagnosed autism (Mottron & Bzdok, 2020). As this issue
is still not resolved, replicating these findings in autistic
samples is essential. Second, it is important to consider
that the variance explained by each regression model is
small, at around 10%. Therefore, there are clearly many
other factors relating to the aging and health variables
presented here. Thus, it is likely that elevated autistic
traits are one of many indicators for poorer aging and
health outcomes. Third, we did not analyze the role of
medication in this study. There are noted adverse meta-
bolic effects from using psychotropic medication
(Bhuvaneswar et al., 2009) which may affect the aging
process; although in the Dunedin cohort, pace of
aging was not affected by antipsychotic medication use
(Wertz et al., 2021). Given that autistic people are often
prescribed antipsychotic medication (both mono-
pharmacy and polypharmacy) in childhood (Spencer
et al., 2013) and adulthood (Esbensen et al., 2009), stud-
ies seeking to replicate these findings in clinical samples
will need to pay careful attention to the role of medica-
tion. In sum, while these preliminary findings highlight a
potential warning sign for poorer aging and health out-
comes, it is essential to highlight that the present findings
need replication with samples of diagnosed autistic
adults, and that the effect of autistic traits on aging and
health outcomes needs more exploration in the context of
other relevant variables (such as medication). A final
point, related to the preceeding points, is the type of
aging trajectory we may expect in older age. The partici-
pants in this study were all aged 45 years of age, but we
would wish to find out about aging in older autistic peo-
ple (i.e., those aged 50 plus). We do not know if the more
rapid aging associated with autistic traits will continue
into older age, or if the association will become stronger
or more attenuated. Future Dunedin research studies can
examine this association over time.
STRENGTHS AND LIMITATIONS
The Dunedin study is a birth cohort study that has been
running for close to five decades. The retention rate of
the cohort is excellent (Poulton et al., 2015). The cohort
is well characterized, and representative of the wider
New Zealand population of European descent. Thus, the
findings from the study are likely generalizable to
European-ancestry populations. This study uses a com-
posite aging variable, derived from 19 biomarkers that
have been collected longitudinally. This is important as
some studies have found null results when examining a
single biomarker for aging in the general population
(e.g., between SES and telomere length; Adams
et al., 2007). It is therefore essential to measure aging
with multiple physiological measures over time.
The study used a brief form of the Autism Quotient
to measure autistic traits at age 45. This is a widely used
screening tool for ASD with multiple studies supporting
its measurement properties (but see Baghdadli
et al., 2017 for a review). We cannot be sure, however,
that elevated AQ-10 scores do not reflect other types of
difficulty instead of autism traits. For example, the items
“I find it easy to do more than one thing at once” and “If
there is an interruption, I can switch back to what I was
doing very quickly” may tap executive dysfunction that is
not uniquely associated with autism (Chang et al., 2020).
Moreover, it is a limitation of this research that the AQ-
10 or a similar autism trait measure was not collected
when the Dunedin participants were children, however,
in the 1970s the prevalence of autism was estimated to be
less than 0.5 in 1000 (Gillberg & Wing, 1999), and for
that reason it was never assessed. Thus, given the relative
“youth” of the autism diagnosis, future studies could
attempt to replicate these findings in samples of diag-
nosed autistic adults. Levels of autistic traits have been
reported to be stable across time, in the general popula-
tion, in both low and high scoring groups, in childhood
to early adolescence (Robinson, Munir, et al., 2011;
Whitehouse et al., 2011). Another general population
study by Taylor et al. (2017) reported a phenotypic stabil-
ity of 0.39 between the ages of 9 and 18 years. It is impor-
tant to note, however, that the stability of autistic traits
into adulthood and older age has yet to be reported. It
could be that a few items on the AQ-10 could be affected
by aging—for example, “I often notice small sounds
when others do not” may be affected by age-related hear-
ing loss (we would expect those higher in autistic traits to
be more likely to endorse this item, so age-related hearing
loss would not be a confound that could explain higher
scores). Longitudinal studies using standardized measures
of autistic traits and health outcomes could explore these
possibilities with samples of older autistic people. Future
work exploring aging and health—including measures of
subjective quality of life, and alternative measures
of autistic traits—using multi-dimensional measures, and
exploring possible mediating factors, could elaborate on
the associations reported here.
CONCLUSION
Data were analyzed from the Dunedin Longitudinal
Study; multiple regression analyses showed that autistic
traits at age 45 were a statistical predictor of both biolog-
ical aging and self- and informant-reports of physical
health. Autistic traits explained variance in both aging
and health variables beyond that explained by childhood
SES and IQ. Given these findings, it seems that those
with high autistic traits may be susceptible to poor health
outcomes, as are diagnosed autistic people (Cashin
et al., 2018; Croen et al., 2015), and may age faster in
midlife. Given that signs of accelerated aging are evident
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at 45, and many chronic conditions of aging emerge later
in life, the findings are concerning for the health of older
people with high autistic traits. Thus, it is vital to
improve healthcare and plan for healthy aging for both
autistic people and those high in autistic traits.
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